MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death

Area of Science:

• Cellular Biology
• Molecular Biology
• Immunology

Background:

• Tumor necrosis factor (TNF) is a key inflammatory cytokine.
• TNF binding to TNFR1 initiates signaling cascades involving NF-κB, p38α, and MK2.
• These pathways regulate gene expression, cell survival, and cell death.

Purpose of the Study:

• To investigate the role of MK2 in TNF-induced cell death pathways.
• To elucidate the mechanism by which MK2 influences RIPK1 activity.
• To understand how RIPK1 phosphorylation impacts apoptosis and necroptosis.

Main Methods:

• Analysis of TNF-induced signaling in cells.
• Biochemical assays to detect RIPK1 phosphorylation at S321 by MK2.
• Site-directed mutagenesis to create phospho-mimetic RIPK1 (S321D) mutants.
• Assessment of cell death (apoptosis and necroptosis) following TNF stimulation.

Main Results:

• TNF-induced MK2 activation leads to global RIPK1 phosphorylation.
• MK2 directly phosphorylates RIPK1 at serine 321 (S321).
• Phosphorylation of RIPK1 at S321 inhibits its interaction with FADD/caspase-8, thereby blocking RIPK1-kinase-dependent apoptosis and necroptosis.
• A phospho-mimetic S321D RIPK1 mutation reduces TNF-induced cell death.
• RIPK1 kinase activation is inhibited by S321 phosphorylation.
• Cytosolic RIPK1 contributes to complex-II-mediated cell death.

Conclusions:

• MK2-mediated phosphorylation of RIPK1 at S321 acts as a critical checkpoint in TNF signaling.
• This phosphorylation event integrates signals for cell survival and cytokine production.
• The findings reveal a novel regulatory mechanism controlling TNF-driven cell fate decisions.